GL1X · GenesisL1 explorer

MolNFT v1 · #121647 · protein

Crystal structure of human germline antibody IGHV5-51/IGKV4-1

5I1L · Fab light chain: “Crystal structure of human germline antibody IGHV5-51/IGKV4-1”. X-ray diffraction, 9 pockets (best druggability 0.74). MolNFT v1 #121647 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5I1L
Type
protein
Length
877 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab light chain; Fab heavy chain
Pockets
9 · best druggability 0.74

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LFab light chainprotein2206% helix, 52% strand—
HFab heavy chainprotein2258% helix, 49% strand—
AFab light chainprotein2196% helix, 53% strand—
BFab heavy chainprotein2139% helix, 54% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains L, H, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16120.740.8174empty
23750.560.7450empty
33070.540.7541empty
4590.510.8722empty
51650.490.7730empty

Interfaces

5 interfaces between chains.

  • L–H · 1876 Ų buried · 15 hydrogen bonds · protein-protein
  • A–B · 1721 Ų buried · 11 hydrogen bonds · protein-protein
  • L–B · 367 Ų buried · 11 hydrogen bonds · protein-protein
  • L–A · 164 Ų buried · 1 hydrogen bond · protein-protein
  • H–B · 163 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 9 disulfide (disulfide).

Compared structures

  • 5I1L · Crystal structure of human germline antibody IGHV5-51/IGKV4-1 · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.